| Product Code: ETC8865480 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Irritable Bowel Syndrome (IBS) Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Irritable Bowel Syndrome (IBS) Market - Industry Life Cycle |
3.4 Poland Irritable Bowel Syndrome (IBS) Market - Porter's Five Forces |
3.5 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Medical Condition, 2021 & 2031F |
3.7 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
4 Poland Irritable Bowel Syndrome (IBS) Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and diagnosis rates of irritable bowel syndrome (IBS) in Poland |
4.2.2 Growing healthcare infrastructure and access to medical services for IBS patients |
4.2.3 Rising demand for effective IBS treatments and management options |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for IBS treatments in Poland |
4.3.2 Lack of standardized treatment protocols for IBS in the country |
4.3.3 Side effects and limitations of current IBS medications impacting patient adherence |
5 Poland Irritable Bowel Syndrome (IBS) Market Trends |
6 Poland Irritable Bowel Syndrome (IBS) Market, By Types |
6.1 Poland Irritable Bowel Syndrome (IBS) Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Lubiprostone, 2021- 2031F |
6.1.4 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Linaclotide, 2021- 2031F |
6.1.5 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Eluxadoline, 2021- 2031F |
6.1.6 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Rifaximin, 2021- 2031F |
6.1.7 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Alosetron, 2021- 2031F |
6.1.8 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Poland Irritable Bowel Syndrome (IBS) Market, By Medical Condition |
6.2.1 Overview and Analysis |
6.2.2 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-Constipation, 2021- 2031F |
6.2.3 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By IBS-diarrhea, 2021- 2031F |
6.2.4 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Mixed, 2021- 2031F |
6.3 Poland Irritable Bowel Syndrome (IBS) Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.3.4 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4 Poland Irritable Bowel Syndrome (IBS) Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Poland Irritable Bowel Syndrome (IBS) Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
7 Poland Irritable Bowel Syndrome (IBS) Market Import-Export Trade Statistics |
7.1 Poland Irritable Bowel Syndrome (IBS) Market Export to Major Countries |
7.2 Poland Irritable Bowel Syndrome (IBS) Market Imports from Major Countries |
8 Poland Irritable Bowel Syndrome (IBS) Market Key Performance Indicators |
8.1 Number of IBS diagnoses reported annually in Poland |
8.2 Percentage increase in healthcare facilities offering specialized IBS treatments |
8.3 Patient satisfaction rates with IBS management strategies |
8.4 Adoption rate of alternative therapies for IBS management |
8.5 Percentage of IBS patients achieving symptom relief with current treatment options |
9 Poland Irritable Bowel Syndrome (IBS) Market - Opportunity Assessment |
9.1 Poland Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 Poland Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Medical Condition, 2021 & 2031F |
9.3 Poland Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 Poland Irritable Bowel Syndrome (IBS) Market Opportunity Assessment, By End-Users, 2021 & 2031F |
10 Poland Irritable Bowel Syndrome (IBS) Market - Competitive Landscape |
10.1 Poland Irritable Bowel Syndrome (IBS) Market Revenue Share, By Companies, 2024 |
10.2 Poland Irritable Bowel Syndrome (IBS) Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here